A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditional SCS Systems
NCT ID: NCT02738840
Last Updated: 2021-06-10
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2016-10-21
2020-12-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Restore Claims Characterization Study
NCT00200122
Algovita Post-Market Clinical Study: Spinal Cord Stimulation to Treat Chronic Pain
NCT02373540
Identifying Biomarkers and Changes in Cerebrospinal Fluid Collected Pre and Post Spinal Cord Stimulation in Subjects Suffering From Chronic Refractory Pain Conditions
NCT03986255
Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of the Trunk and/or Limbs
NCT02143791
Impact of Subcutaneous Electric Lumbar Stimulation on Treatment of Refractory Chronic and Disabling Lumbago
NCT02988830
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prodigy MRI or Proclaim Elite MR
The Prodigy MRI system is only MR conditional for scans of the head and extremities (upper except shoulder, lower except hip).
The Proclaim Elite system is MR conditional for scans of the head, extremities or any other body part.
MRI scan
MRI scan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI scan
MRI scan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient will receive an MRI scan in compliance with the Instructions For Use (IFU) for the implanted MR conditional SCS system
* Patient is ≥ 18 years of age
* Patient must be willing and able to comply with study requirements
* Patient must indicate his/her understanding of the study and willingness to participate by signing an appropriate Informed Consent Form
Exclusion Criteria
* Patient has previously experienced an MRI scan-related adverse event
* Patient is currently enrolled in another Abbott study that collects MRI safety data
* Patient is incapacitated, is unable to read or write, or is pregnant or breastfeeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicole Harbert
Role: STUDY_DIRECTOR
Abbott
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Napa Valley Orthopedic Medical Group
Napa, California, United States
Unity Spine Center
Rochester, New York, United States
Clinical Trials of South Carolina
Charleston, South Carolina, United States
Wilhelminenspital Wien
Vienna, , Austria
AZ Sint-Augustinus
Wilrijk, , Belgium
Medizinische Einrichtungen der Universität Düsseldorf, Dusseldorf
Düsseldorf, , Germany
Hospital Gera -Zentrum für interdisziplinäre Schmerztherapie, Gera
Gera, , Germany
Azienda Ospedaliero Universitaria Pisana
Pisa, , Italy
Hospital Virgen de Rocio
Seville, , Spain
Seacroft Hospital
Leeds, Ykshre, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRD_800
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.